Clinical Research Directory

Inclusion Criteria: AR-patients identified by having at least two dispensations of prescribed AR medications for two consecutive years and/or ICD10-codes of AR in specialty care For the SQ SLIT-tablet cohort: \- at least 2 dispensations within 365 days of SQ SLIT-tablets (ATC: V01AA02 and V01AA03) For the control cohort: \- unexposed subjects will be identified from the study population of AR-patients that may be eligible to receive SQ SLIT-tablets, but have not dispensed a prescription of SQ SLIT-tablets during the index year of the case or prior to that year Exclusion Criteria: \- Any allergy immunotherapy treatment prior to the index event